Bausch Health
BHC
#4534
Rank
S$2.88 B
Marketcap
S$7.78
Share price
3.37%
Change (1 day)
-18.77%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): S$1.25

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is S$1.23. In 2024 the company made an earnings per share (EPS) of S-$0.15 an increase over its 2023 EPS that were of S-$2.05.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$1.25-922.86%
2024S-$0.15-92.59%
2023S-$2.05160.89%
2022S-$0.79-76.64%
2021S-$3.3768.45%
2020S-$2.00-68.91%
2019S-$6.44-57.11%
2018S-$15.01-272.22%
2017S$8.72-199.29%
2016S-$8.78798.7%
2015S-$0.98-128.31%
2014S$3.45-204.62%
2013S-$3.30602.7%
2012S-$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.30-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.21-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA